M. Hatanaka

Re-evaluation of chromosomal aberration induction on nine mouse lymphoma assay ‘unique positive’ NTP carcinogens

Atsuko Matsuoka, Kohji Yamakage, Hirokazu Kusakabe et al. · Mutation Research/Genetic Toxicology · 1996 · 62 citations

Pharmacy, Oncology, Toxicology +13

Effects of Dibutyryl Cyclic Adenosine Phosphate Plus Theophylline on Murine Sarcoma Virus Transformed Non-Producer Cells

A F Gazdar, M. Hatanaka, R. Herberman et al. · Experimental Biology and Medicine · 1972 · 20 citations

Life Sciences, Cell Biology, Molecular Biology +12

Assignment of the human calpastatin gene (CAST) to chromosome 5 at region q14→q22

Johji Inazawa, Hiroyuki Nakagawa, S Misawa et al. · Cytogenetics and Cell Genetics · 2008 · 18 citations

Life Sciences, Genetics, Molecular Genetics +11

Cytogenetic effects of a food mutagen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), and its metabolite, 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine (N-OH-PhIP), on human and Chinese hamster cells in vitro

Chino Otsuka, Kunihiko Miura, Takatomo Satoh et al. · Mutation Research/Genetic Toxicology · 1996 · 16 citations

Pharmacy, Genetics, Toxicology +16

Cyclic AMP-mediated inhibition of cell growth by prostaglandin D2 in a fibroblastic cell line (EBTr).

Emiko Okuda‐Ashitaka, Masahiko Negishi, Kazushige Sugama et al. · PubMed · 1990 · 14 citations

Life Sciences, Biochemistry, Cell Biology +16